BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 20074922)

  • 1. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis.
    Deb P; Sharma S; Hassan KM
    Pathophysiology; 2010 Jun; 17(3):197-218. PubMed ID: 20074922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and therapeutic strategies in the management of stroke: an update.
    Kumar A; Dogra S
    Drugs Today (Barc); 2008 Oct; 44(10):757-66. PubMed ID: 19137129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations and treatment strategies for the management of acute ischemic stroke.
    Segura T; Calleja S; Jordan J
    Expert Opin Pharmacother; 2008 May; 9(7):1071-85. PubMed ID: 18422467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in ischemic stroke treatment: neuroprotective and combination therapies.
    Lapchak PA; Araujo DM
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):97-112. PubMed ID: 17355216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.
    Sahota P; Savitz SI
    Neurotherapeutics; 2011 Jul; 8(3):434-51. PubMed ID: 21604061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
    Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of neuroprotection in acute ischemic stroke].
    Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
    Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mechanisms in ischemic stroke: therapeutic approaches.
    Lakhan SE; Kirchgessner A; Hofer M
    J Transl Med; 2009 Nov; 7():97. PubMed ID: 19919699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine.
    Seto SW; Chang D; Jenkins A; Bensoussan A; Kiat H
    J Clin Med; 2016 Jun; 5(6):. PubMed ID: 27275837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
    Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
    Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke.
    Bazan HA; Zea N; Jennings B; Smith TA; Vidal G; Sternbergh WC
    J Vasc Surg; 2015 Dec; 62(6):1529-38. PubMed ID: 26412434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic hypothermia for acute ischemic stroke.
    Froehler MT; Ovbiagele B
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):593-603. PubMed ID: 20397832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: a continued promise for neuroprotection.
    Yang ZS; Mu J
    Med Gas Res; 2017; 7(1):68-73. PubMed ID: 28480034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen.
    Hobohm C; Laignel F; Kacza J; Küppers-Tiedt L; Heindl M; Schneider D; Grosche J; Härtig W; Michalski D
    Brain Res; 2011 Oct; 1417():115-26. PubMed ID: 21914554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?
    Lebeurrier N; Vivien D; Ali C
    Expert Opin Ther Targets; 2004 Aug; 8(4):309-20. PubMed ID: 15268626
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.